Primobolan tablets 5 mg for osteoporosis and anemia

General information on Japanese Primobolan tablets 5 mg for osteoporosis and anemia   

Package details: 100 tablets

Manufacturer: Bayer Yakuhin, Ltd., Japan

Active ingredient: methenolone acetate (chemical formula C22H32O3)

Medical effect: Primobolan tablets are effective for the following purposes:

• treatment of osteoporosis,
• treatment of severe exhaustion due to chronic renal disease,
• malignant tumor treatment,
• external injury or burn treatment,
• wasting of the bone marrow due to aplastic anemia.

Contraindications and precautions: do not use in patients who have or are suspected of having prostate cancer. Do not use in pregnant or breastfeeding women. If an allergic reaction occurs, stop using the medication and consult with your doctor. If you’re taking any other medication, please consult with your doctor before use.

Dosage and administration of Japanese Primobolan tablets 5 mg for osteoporosis and anemia

Adults should take 2-4 tablets a day, dividing into 2 or 3 times. The dosage may be adjusted by the consulting doctor due to age and symptoms.

How effective are Primobolan tablets 5 mg from Japan for osteoporosis and anemia?

Primobolan tablets contain 5 mg of methenolone acetate (metenolone acetate) in each tablet. This synthetic androstane steroid helps to store calcium, phosphorus and nitrogen through protein anabolism. Primobolan tablets improve bone strength and improve symptoms of severe physical exhaustion. Also, this medicine effectively increases the amount of hemoglobin and number of red blood cells.

Who should use Primobolan tablets 5 mg from Japan?

Primobolan tablets are prescribed for patients with osteoporosis, anemia due to bone marrow failure, severe exhaustion due to chronic renal disease, malignant tumor, external injury or burn. Studies showed that methenolone acetate is generally well-tolerated, and more than 40% of patients with anemia had a favorable response to the medicine (K. Shimoda, K. Shide et al. The Effect of Anabolic Steroids on Anemia in Myelofibrosis With Myeloid Metaplasia // International journal of hematology. 2007, May, 85(4): 338-343).